Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

65
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
65
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

80
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
80
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

23
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
23
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

28
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
28
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

28
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
28
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

36
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.

The Journal of antimicrobial chemotherapy·2026
Same author

Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.

PloS one·2025
Same author

Bladder pain syndrome and sexual function: a systematic review and meta-analysis.

International urogynecology journal·2023
Same author

A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship.

JAC-antimicrobial resistance·2022
Same author

Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.

Annals of internal medicine·2021
Same journal

Comment on: An improved algorithm to screen for carbapenemase production in <i>Pseudomonas aeruginosa</i>.

JAC-antimicrobial resistance·2026
Same journal

Antibiotic prescribing practices and appropriateness of prescriptions in outpatient paediatric acute respiratory tract infections in Viet Nam.

JAC-antimicrobial resistance·2026
Same journal

Pre-emptive versus empirical antifungal therapy in patients with febrile neutropenia with acute leukaemia: a GIMEMA study.

JAC-antimicrobial resistance·2026
Same journal

Linking access to stewardship: a pathway for introducing reserve antibiotics in India.

JAC-antimicrobial resistance·2026
Same journal

ADVANCE-ID bacterial and fungal infections review: antimicrobial resistance research updates: Summary of clinical trials and implementation studies, March-April 2026.

JAC-antimicrobial resistance·2026
Same journal

Epidermicin NI01 demonstrates potent <i>in vivo</i> activity in a murine model of methicillin-resistant <i>Staphylococcus aureus</i> skin infection.

JAC-antimicrobial resistance·2026
See all related articles

Related Experiment Video

Updated: Aug 14, 2025

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

630

Staphylococcus aureus bacteriuria: implications and management.

C Y Mason1, A Sobti1, A L Goodman1,2

  • 1Department of Infectious Diseases, Guy's and St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK.

Jac-Antimicrobial Resistance
|January 16, 2023
PubMed
Summary
This summary is machine-generated.

Staphylococcus aureus in urine cultures is common, but routine blood tests and treatment for asymptomatic cases are not usually needed. Focus on high-risk patients and consider repeat urine cultures for better management.

More Related Videos

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.2K
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

234

Related Experiment Videos

Last Updated: Aug 14, 2025

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

630
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.2K
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

234

Area of Science:

  • Urology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Staphylococcus aureus commonly appears in urine cultures, particularly in older patients, those with comorbidities, or urinary tract issues.
  • Its presence can indicate contamination, colonization, infection, or seeding from another site, often linked to S. aureus bacteremia.
  • Current guidance for managing S. aureus bacteriuria is limited, necessitating further clinical investigation.

Purpose of the Study:

  • To analyze the clinical characteristics, investigations, and management of S. aureus bacteriuria.
  • To evaluate the necessity of routine blood cultures and antibiotic treatment for S. aureus bacteriuria.
  • To develop a management algorithm for S. aureus bacteriuria.

Main Methods:

  • Retrospective analysis of adult patients with S. aureus in urine cultures over a 5-year period.
  • Detailed investigation and management analysis for cases identified over a 1-year period.
  • Collection of data on clinical characteristics, investigations, and treatment outcomes.

Main Results:

  • S. aureus was found in 6.5% of positive urine cultures, with MRSA identified in 6.5% of cases.
  • S. aureus bacteremia occurred in 6.4% of patients with blood cultures, often linked to urological procedures.
  • Antibiotics were given to 57% and repeat urine cultures to 49% of analyzed cases; recurrence factors included catheterization, urological abnormality, diabetes, and inpatient status.

Conclusions:

  • Routine blood cultures and treatment of asymptomatic S. aureus bacteriuria in stable patients are not supported by this study.
  • Repeat urine cultures and targeted investigations/treatment for high-risk individuals, especially before bladder instrumentation, are recommended.
  • A simple algorithm is proposed to guide clinical decision-making for S. aureus bacteriuria.